Lars Fruergaard Jørgensen, Novo Nordisk CEO (Graeme Sloan/Sipa USA)(Sipa via AP Images)

No­vo Nordisk to de­crease some in­sulin pen man­u­fac­tur­ing, tran­si­tion sup­ply

No­vo Nordisk has told gov­ern­ment and glob­al non­prof­its that it plans to sig­nif­i­cant­ly down­size its man­u­fac­tur­ing of some of its in­sulin pens, ac­cord­ing to one …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA